Skip to main content

September 2018 Vol 11, No 6

Clinical, Original Research
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
Craig White, PhD; Winghan Jacqueline Kwong, PharmD, PhD; Hilary Armstrong, PhD; Michael Behling; Jeffrey Niemira; Kathy Lang, PhD
Stakeholder Perspective
Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage
F. Randy Vogenberg, PhD, RPh
Read More
Editorial
"The Dirty Dozen"
David B. Nash, MD, MBA
Read More
Original Research, Regulatory
Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015
Xiaomeng Yue, BPharm, MS; Jeff Jianfei Guo, BPharm, MS, PhD; Patricia R. Wigle, PharmD
Stakeholder Perspective
The Importance and Benefits of Smoking-Cessation Therapy
Jack E. Fincham, PhD, RPh
Read More
Business, Original Research
Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies
Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh
Read More

Results 1 - 4 of 4